These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1080165)

  • 21. Use of dimethylmyleran in adoptive chemoimmunotherapy of two murine leukemias.
    Einstein AB; Cheever MA; Fefer A
    J Natl Cancer Inst; 1976 Mar; 56(3):609-13. PubMed ID: 768503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor neutralization, immunotherapy, and chemoimmmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro.
    Cheever MA; Kempf RA; Fefer A
    J Immunol; 1977 Aug; 119(2):714-8. PubMed ID: 886192
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response.
    Ting CC; Rodgigues D; Bushar GS; Herberman RB
    J Immunol; 1976 Jan; 116(1):236-43. PubMed ID: 54387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.
    Klarnet JP; Matis LA; Kern DE; Mizuno MT; Peace DJ; Thompson JA; Greenberg PD; Cheever MA
    J Immunol; 1987 Jun; 138(11):4012-7. PubMed ID: 3108381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
    Ye QW; Mokyr MB
    Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ineffectiveness of adoptive chemoimmunotherapy with lymphokine-activated killer cells, interleukin-2, and cyclophosphamide on palpable intradermal murine bladder cancer.
    Lee K; O'Donnell RW; Cockett AT
    J Biol Response Mod; 1988 Feb; 7(1):43-53. PubMed ID: 3259620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of established tumor by adoptive immunotherapy with specifically immune T cells.
    Greenberg PD; Cheever MA
    Surv Immunol Res; 1985; 4(4):283-96. PubMed ID: 3879738
    [No Abstract]   [Full Text] [Related]  

  • 29. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: effect of culture duration on therapeutic efficacy.
    Cheever MA; Greenberg PD; Fefer A
    J Natl Cancer Inst; 1981 Jul; 67(1):169-73. PubMed ID: 6942187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adoptive immunotherapy and chemo-immunotherapy in murine L-1210 leukemia and its influence on the kinetics of leukemic proliferation.
    Rytwiński K
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):819-27. PubMed ID: 549532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.
    Greenberg PD; Cheever MA; Fefer A
    J Exp Med; 1981 Sep; 154(3):952-63. PubMed ID: 6974221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immunity to friend virus-induced leukemia. IV. In vitro generation of primary and secondary cell-mediated cytotoxic responses.
    Ting CC; Bonnard GD
    J Immunol; 1976 May; 116(5):1419-25. PubMed ID: 58034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of leukemia regression in mice by immunotherapeutic transfer of T-lymphocytes.
    Johnson CS; Thurlow SM; Furmanski P
    Cancer Res; 1986 Jan; 46(1):183-9. PubMed ID: 3079585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells.
    Greenberg PD; Cheever MA
    J Immunol; 1984 Dec; 133(6):3401-7. PubMed ID: 6149246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M; Keys LD; Gaston M; Goldin A
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.